相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。cAMP-Dependent Cytosolic Mislocalization of p27kip-Cyclin D1 During Quinol-Thioether-Induced Tuberous Sclerosis Renal Cell Carcinoma
Jennifer D. Cohen et al.
TOXICOLOGICAL SCIENCES (2011)
Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column
Koshi Imami et al.
ANALYTICAL SCIENCES (2008)
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth
Jingxiang Huang et al.
BIOCHEMICAL JOURNAL (2008)
Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
Bing-Hua Jiang et al.
DRUG RESISTANCE UPDATES (2008)
Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis
Greg T. Cantin et al.
JOURNAL OF PROTEOME RESEARCH (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
A quantitative atlas of mitotic phosphorylation
Noah Dephoure et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
John P. Alao
MOLECULAR CANCER (2007)
ERK activity and G1 phase progression: Identifying dispensable versus essential activities and primary versus secondary targets
Jessie Villanueva et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry
Henrik Molina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis
Federico Rojo et al.
CLINICAL CANCER RESEARCH (2007)
Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer
Josep Castellvi et al.
CANCER (2006)
Expression of mTOR signaling pathway markers in prostate cancer progression
Celeste L. Kremer et al.
PROSTATE (2006)
Rational design of inhibitors that bind to inactive kinase conformations
Y Liu et al.
NATURE CHEMICAL BIOLOGY (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization
MJ Garnett et al.
MOLECULAR CELL (2005)
Rheb binds and regulates the mTOR kinase
X Long et al.
CURRENT BIOLOGY (2005)
Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells
HS Yoon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent
M Karbowniczek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The RAF proteins take centre stage
C Wellbrock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1
A Beugnet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of cyclin D1 expression by the ERK5 cascade
R Mulloy et al.
ONCOGENE (2003)
Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb
AR Tee et al.
CURRENT BIOLOGY (2003)
Tumour suppressors hamartin and tuberin: intracellular signalling
VP Krymskaya
CELLULAR SIGNALLING (2003)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides
K Gevaert et al.
NATURE BIOTECHNOLOGY (2003)
Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes
CJ Nelsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat
SK Patel et al.
MOLECULAR CARCINOGENESIS (2003)
Multiple roles of the tuberous sclerosis complex genes
RS Yeung
GENES CHROMOSOMES & CANCER (2003)
Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity
HS Yoon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene
HS Yoon et al.
MOLECULAR CARCINOGENESIS (2001)
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
M Hidalgo et al.
ONCOGENE (2000)
分享论文
